Evidence map›Paper›PMID 30948788›Full record

ReviewCell research2019

The molecular machinery of regulated cell death.

Daolin Tang, Rui Kang, Tom Vanden Berghe, Peter Vandenabeele, Guido Kroemer

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,547 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,547citing papers in PubMed, 2 pooled it
75.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,547 citing papers in PubMed, 2 syntheses or guidelines pooled it, 2,454 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. The emerging roles of disulfidptosis in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  18. Itaconate metabolism in regulated cell death.Molecular and cellular biochemistry · 2026
    Review
  19. Article
  20. Review

1,487 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

Daolin TangThe Third Affiliated Hospital, Protein Modification and Degradation Lab, School of Basic Medical Sciences, Guangzhou Medical University, 510510, Guangzhou, Guangdong, China. daolin.tang@utsouthwestern.edu.
Rui KangDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX, 75390, USA.
Tom Vanden BergheMolecular Signaling and Cell Death Unit, VIB-UGent Center for Inflammation Research, Flanders Institute for Biotechnology, 9052, Ghent, Belgium.
Peter VandenabeeleMolecular Signaling and Cell Death Unit, VIB-UGent Center for Inflammation Research, Flanders Institute for Biotechnology, 9052, Ghent, Belgium.ORCID http://orcid.org/0000-0002-6669-8822
Guido KroemerUniversité Paris Descartes, Sorbonne Paris Cité, 75006, Paris, France. kroemer@orange.fr.
University College Ghent · BEDélégation Paris 5 · FRGuangzhou University · CNSouthwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells may die from accidental cell death (ACD) or regulated cell death (RCD). ACD is a biologically uncontrolled process, whereas RCD involves tightly structured signaling cascades and molecularly defined effector mechanisms. A growing number of novel non-apoptotic forms of RCD have been identified and are increasingly being implicated in various human pathologies. Here, we critically review the current state of the art regarding non-apoptotic types of RCD, including necroptosis, pyroptosis, ferroptosis, entotic cell death, netotic cell death, parthanatos, lysosome-dependent cell death, autophagy-dependent cell death, alkaliptosis and oxeiptosis. The in-depth comprehension of each of these lethal subroutines and their intercellular consequences may uncover novel therapeutic targets for the avoidance of pathogenic cell loss.

Indexed as

Regulated Cell DeathAntioxidantsCaspasesDNAHumansMembrane ProteinsOxidative StressProtein KinasesReactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine KinasesAntioxidantsCaspasesDNAMembrane ProteinsProtein KinasesReactive Oxygen SpeciesReceptor-Interacting Protein Serine-Threonine Kinases

Identifiers

PMID30948788
PMCPMC6796845
OpenAlexW2935369648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.